Light therapy: Early response does not predict long-term outcomeMost patients with seasonal affective disorder respond after six weeks of treatment Aripiprazole depot injection delays schizophrenia relapseOnce-monthly treatment may improve compliance Openers: CADTH Corner Uncharted territory for those with schizophrenia. Depressed? Stick needles in your head Acupuncture promising as add-on therapy There’s an app for... problem gambling New tools aim to reduce or stop harmful activity through self-monitoring Physiotherapists, psychologists to prescribe in Australia MDs fear proposal jeopardizes patient safety Saphris: new atypical antipsychotic New drug indicated for treatment of schizophrenia, acute treatment of manic or mixed episodes associated with bipolar I disorder. Depressed heart patients recover more slowly from exercise Sympathetic dysregulation may help explain worse outcomes in these patients Champix may help reduce alcohol consumption Smoking-cessation drug varenicline (marketed as Champix in Canada) may have potential as a means of reducing alcohol consumption Clinical Notes: Guidelines for monitoring atypical antipsychotics in children Group issues three sets of recommendations concerning the monitoring and management of adverse effects. First Previous 58 59 60 61 62 Next Last
